Related Experiment Video

Updated: May 14, 2026

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
07:03

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Published on: July 19, 2024

A critical appraisal of advances in pediatric nonalcoholic Fatty liver disease

Nadia Ovchinsky1, Joel E Lavine

  • 1Department of Pediatrics, Columbia College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. no2021@columbia.edu

Seminars in Liver Disease
|February 12, 2013
PubMed

Insights

Nonalcoholic fatty liver disease (NAFLD) is a growing concern in children, linked to obesity. Current research focuses on its causes, genetics, and effective treatments like lifestyle changes and antioxidants.

Area of Science:

  • Pediatrics
  • Hepatology
  • Genetics

Background:

  • Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver condition in pediatric populations.
  • The increasing incidence of childhood obesity is strongly associated with the rise in pediatric NAFLD.
  • Understanding the unique histologic features and genetic underpinnings of pediatric NAFLD is crucial.

Purpose of the Study:

  • To provide a comprehensive review of current knowledge regarding pediatric NAFLD.
  • To cover epidemiology, pathophysiology, genetic factors, diagnosis, and treatment strategies.
  • To highlight recent advancements and ongoing research in the field.

Main Methods:

  • Review of current scientific literature on pediatric NAFLD.
  • Synthesis of information on disease mechanisms, diagnostic criteria, and therapeutic approaches.
  • Analysis of findings from recent clinical trials involving lifestyle interventions and antioxidants.

Main Results:

  • Pediatric NAFLD exhibits distinct histologic patterns compared to adults.
  • Liver biopsy remains the gold standard for diagnosing nonalcoholic steatohepatitis (NASH) in children.
  • Lifestyle modifications promoting weight loss are the primary treatment, with antioxidants showing promise in trials.

Conclusions:

  • NAFLD is a significant pediatric health issue requiring continued investigation.
  • Integrated approaches combining lifestyle changes and potential pharmacological agents are key for management.
  • Further research is essential to refine diagnostic and therapeutic strategies for pediatric NAFLD.

More Related Videos

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: